Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Comparative virology of HTLV-1 and HTLV-2.

Martinez MP, Al-Saleem J, Green PL.

Retrovirology. 2019 Aug 7;16(1):21. doi: 10.1186/s12977-019-0483-0. Review.

2.

HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.

Al-Saleem J, Dirksen WP, Martinez MP, Shkriabai N, Kvaratskhelia M, Ratner L, Green PL.

PLoS One. 2019 Mar 21;14(3):e0214059. doi: 10.1371/journal.pone.0214059. eCollection 2019.

3.

CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus.

Panfil AR, London JA, Green PL, Yoder KE.

Front Microbiol. 2018 Dec 14;9:3107. doi: 10.3389/fmicb.2018.03107. eCollection 2018. Review.

4.

SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice.

Kodigepalli KM, Li M, Bonifati S, Panfil AR, Green PL, Liu SL, Wu L.

Cell Cycle. 2018;17(23):2564-2576. doi: 10.1080/15384101.2018.1550955. Epub 2018 Dec 4.

PMID:
30474474
5.

Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.

Nakagawa M, Shaffer AL 3rd, Ceribelli M, Zhang M, Wright G, Huang DW, Xiao W, Powell J, Petrus MN, Yang Y, Phelan JD, Kohlhammer H, Dubois SP, Yoo HM, Bachy E, Webster DE, Yang Y, Xu W, Yu X, Zhao H, Bryant BR, Shimono J, Ishio T, Maeda M, Green PL, Waldmann TA, Staudt LM.

Cancer Cell. 2018 Aug 13;34(2):286-297.e10. doi: 10.1016/j.ccell.2018.06.014. Epub 2018 Jul 26.

6.

Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice.

Huey DD, Bolon B, La Perle KMD, Kannian P, Jacobson S, Ratner L, Green PL, Niewiesk S.

Comp Med. 2018 Feb 1;68(1):4-14.

7.

Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.

Panfil AR, Al-Saleem J, Howard CM, Shkriabai N, Kvaratskhelia M, Green PL.

Front Microbiol. 2018 Jan 30;9:80. doi: 10.3389/fmicb.2018.00080. eCollection 2018.

8.

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice.

Esser AK, Rauch DA, Xiang J, Harding JC, Kohart NA, Ross MH, Su X, Wu K, Huey D, Xu Y, Vij K, Green PL, Rosol TJ, Niewiesk S, Ratner L, Weilbaecher KN.

Oncotarget. 2017 Aug 27;8(41):69250-69263. doi: 10.18632/oncotarget.20565. eCollection 2017 Sep 19.

9.

Correction: PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.

Webb LM, Amici SA, Jablonski KA, Savardekar H, Panfil AR, Li L, Zhou W, Peine K, Karkhanis V, Bachelder EM, Ainslie KM, Green PL, Li C, Baiocchi RA, Guerau-de-Arellano M.

J Immunol. 2017 Oct 15;199(8):3004. doi: 10.4049/jimmunol.1701237. No abstract available.

10.

Human Genetic Determinants of Viral Diseases.

Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS.

Annu Rev Genet. 2017 Nov 27;51:241-263. doi: 10.1146/annurev-genet-120116-023425. Epub 2017 Aug 30. Review.

11.

Methods for Identifying and Examining HTLV-1 HBZ Post-translational Modifications.

Al-Saleem J, Kvaratskhelia M, Green PL.

Methods Mol Biol. 2017;1582:111-126. doi: 10.1007/978-1-4939-6872-5_9.

PMID:
28357666
12.

PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.

Webb LM, Amici SA, Jablonski KA, Savardekar H, Panfil AR, Li L, Zhou W, Peine K, Karkhanis V, Bachelder EM, Ainslie KM, Green PL, Li C, Baiocchi RA, Guerau-de-Arellano M.

J Immunol. 2017 Feb 15;198(4):1439-1451. doi: 10.4049/jimmunol.1601702. Epub 2017 Jan 13. Erratum in: J Immunol. 2017 Oct 15;199(8):3004.

13.

Human T-cell leukemia virus-associated malignancy.

Panfil AR, Martinez MP, Ratner L, Green PL.

Curr Opin Virol. 2016 Oct;20:40-46. doi: 10.1016/j.coviro.2016.08.009. Epub 2016 Aug 31. Review.

14.

Finding the "Right-Size" Physical Therapy Workforce: International Perspective Across 4 Countries.

Jesus TS, Koh G, Landry M, Ong PH, Lopes AM, Green PL, Hoenig H.

Phys Ther. 2016 Oct;96(10):1597-1609. Epub 2016 May 5.

PMID:
27149960
15.

Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.

Panfil AR, Dissinger NJ, Howard CM, Murphy BM, Landes K, Fernandez SA, Green PL.

J Virol. 2016 Jan 27;90(7):3760-72. doi: 10.1128/JVI.03113-15.

16.

HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.

Kawatsuki A, Yasunaga JI, Mitobe Y, Green PL, Matsuoka M.

Oncogene. 2016 Aug 25;35(34):4509-17. doi: 10.1038/onc.2015.510. Epub 2016 Jan 25.

17.

PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival.

Panfil AR, Al-Saleem J, Howard CM, Mates JM, Kwiek JJ, Baiocchi RA, Green PL.

Viruses. 2015 Dec 30;8(1). pii: E7. doi: 10.3390/v8010007.

18.

Bayesian and Markov chain Monte Carlo methods for identifying nonlinear systems in the presence of uncertainty.

Green PL, Worden K.

Philos Trans A Math Phys Eng Sci. 2015 Sep 28;373(2051). pii: 20140405. doi: 10.1098/rsta.2014.0405. Review.

19.

Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.

Takachi T, Takahashi M, Takahashi-Yoshita M, Higuchi M, Obata M, Mishima Y, Okuda S, Tanaka Y, Matsuoka M, Saitoh A, Green PL, Fujii M.

Cancer Sci. 2015 Apr;106(4):461-5. doi: 10.1111/cas.12618. Epub 2015 Mar 16.

20.

Identification and characterization of HTLV-1 HBZ post-translational modifications.

Dissinger N, Shkriabai N, Hess S, Al-Saleem J, Kvaratskhelia M, Green PL.

PLoS One. 2014 Nov 12;9(11):e112762. doi: 10.1371/journal.pone.0112762. eCollection 2014.

21.

The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle.

Anupam R, Doueiri R, Green PL.

Front Microbiol. 2013 Sep 17;4:275. doi: 10.3389/fmicb.2013.00275. Review.

22.

BET proteins promote efficient murine leukemia virus integration at transcription start sites.

Sharma A, Larue RC, Plumb MR, Malani N, Male F, Slaughter A, Kessl JJ, Shkriabai N, Coward E, Aiyer SS, Green PL, Wu L, Roth MJ, Bushman FD, Kvaratskhelia M.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12036-41. doi: 10.1073/pnas.1307157110. Epub 2013 Jul 1.

23.

Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.

Kannian P, Fernandez S, Jones KS, Green PL.

J Virol. 2013 Aug;87(16):9344-52. doi: 10.1128/JVI.01079-13. Epub 2013 Jun 19.

24.

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.

Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S.

Retrovirology. 2013 Feb 13;10:19. doi: 10.1186/1742-4690-10-19.

25.

Animal Models Utilized in HTLV-1 Research.

Panfil AR, Al-Saleem JJ, Green PL.

Virology (Auckl). 2013 Nov 18;4:49-59. doi: 10.4137/VRT.S12140. eCollection 2013. Review.

26.

Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.

Doueiri R, Anupam R, Kvaratskhelia M, Green KB, Lairmore MD, Green PL.

Retrovirology. 2012 Aug 9;9:64. doi: 10.1186/1742-4690-9-64.

27.

Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.

Yin H, Kannian P, Dissinger N, Haines R, Niewiesk S, Green PL.

J Virol. 2012 Aug;86(16):8412-21. doi: 10.1128/JVI.00717-12. Epub 2012 May 23.

28.

Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.

Kannian P, Yin H, Doueiri R, Lairmore MD, Fernandez S, Green PL.

J Virol. 2012 Apr;86(7):3757-66. doi: 10.1128/JVI.06900-11. Epub 2012 Jan 25.

29.

Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Lairmore MD, Anupam R, Bowden N, Haines R, Haynes RA 2nd, Ratner L, Green PL.

Viruses. 2011 Jul;3(7):1131-65. doi: 10.3390/v3071131. Epub 2011 Jul 12. Review.

30.

Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Kannian P, Green PL.

Viruses. 2010 Sep;2(9):2037-77. doi: 10.3390/v2092037. Epub 2010 Sep 24.

31.

Human T lymphotropic virus type 1 regulatory and accessory gene transcript expression and export are not rex dependent.

Li M, Kannian P, Yin H, Kesic M, Green PL.

AIDS Res Hum Retroviruses. 2012 Apr;28(4):405-10. doi: 10.1089/aid.2011.0130. Epub 2011 Aug 5.

32.

HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.

Zhao T, Satou Y, Sugata K, Miyazato P, Green PL, Imamura T, Matsuoka M.

Blood. 2011 Aug 18;118(7):1865-76. doi: 10.1182/blood-2010-12-326199. Epub 2011 Jun 24.

33.

HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.

Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, Yamaguchi T, Ono M, Sakaguchi S, Matsuoka M.

PLoS Pathog. 2011 Feb 10;7(2):e1001274. doi: 10.1371/journal.ppat.1001274.

34.

Cloaked virus slips between cells.

Jones KS, Green PL.

Nat Med. 2010 Jan;16(1):25-7. doi: 10.1038/nm0110-25. No abstract available.

35.

Phosphorylation regulates human T-cell leukemia virus type 1 Rex function.

Kesic M, Doueiri R, Ward M, Semmes OJ, Green PL.

Retrovirology. 2009 Nov 17;6:105. doi: 10.1186/1742-4690-6-105.

36.

The HBZ gene, a key player in HTLV-1 pathogenesis.

Matsuoka M, Green PL.

Retrovirology. 2009 Aug 3;6:71. doi: 10.1186/1742-4690-6-71. Review.

37.

Site-specific phosphorylation regulates human T-cell leukemia virus type 2 Rex function in vivo.

Kesic M, Ward M, Semmes OJ, Green PL.

J Virol. 2009 Sep;83(17):8859-68. doi: 10.1128/JVI.00908-09. Epub 2009 Jun 24.

38.

Human T-cell leukemia virus type 2 Rex carboxy terminus is an inhibitory/stability domain that regulates Rex functional activity and viral replication.

Xie L, Kesic M, Yamamoto B, Li M, Younis I, Lairmore MD, Green PL.

J Virol. 2009 May;83(10):5232-43. doi: 10.1128/JVI.02271-08. Epub 2009 Mar 11.

39.

Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals.

Li M, Kesic M, Yin H, Yu L, Green PL.

J Virol. 2009 Apr;83(8):3788-97. doi: 10.1128/JVI.02315-08. Epub 2009 Feb 4.

40.

Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.

Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL.

Blood. 2008 Nov 1;112(9):3788-97. doi: 10.1182/blood-2008-04-154286. Epub 2008 Aug 8.

41.

Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation.

Nadella MV, Shu ST, Dirksen WP, Thudi NK, Nadella KS, Fernandez SA, Lairmore MD, Green PL, Rosol TJ.

Retrovirology. 2008 Jun 9;5:46. doi: 10.1186/1742-4690-5-46.

42.

Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.

Yamamoto B, Li M, Kesic M, Younis I, Lairmore MD, Green PL.

Retrovirology. 2008 May 12;5:38. doi: 10.1186/1742-4690-5-38.

43.

Multiple facets of junD gene expression are atypical among AP-1 family members.

Hernandez JM, Floyd DH, Weilbaecher KN, Green PL, Boris-Lawrie K.

Oncogene. 2008 Aug 14;27(35):4757-67. doi: 10.1038/onc.2008.120. Epub 2008 Apr 21. Review.

44.

RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1.

Bolinger C, Yilmaz A, Hartman TR, Kovacic MB, Fernandez S, Ye J, Forget M, Green PL, Boris-Lawrie K.

Nucleic Acids Res. 2007;35(8):2629-42. Epub 2007 Apr 10.

45.

Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.

Li M, Green PL.

J Virol Methods. 2007 Jun;142(1-2):159-68. Epub 2007 Mar 6.

46.

Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein.

Ishioka K, Higuchi M, Takahashi M, Yoshida S, Oie M, Tanaka Y, Takahashi S, Xie L, Green PL, Fujii M.

Retrovirology. 2006 Oct 17;3:71.

47.

Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling.

Twizere JC, Springael JY, Boxus M, Burny A, Dequiedt F, Dewulf JF, Duchateau J, Portetelle D, Urbain P, Van Lint C, Green PL, Mahieux R, Parmentier M, Willems L, Kettmann R.

Blood. 2007 Feb 1;109(3):1051-60. Epub 2006 Sep 21.

48.

Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.

Hiraragi H, Kim SJ, Phipps AJ, Silic-Benussi M, Ciminale V, Ratner L, Green PL, Lairmore MD.

J Virol. 2006 Apr;80(7):3469-76.

49.

Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.

Arnold J, Yamamoto B, Li M, Phipps AJ, Younis I, Lairmore MD, Green PL.

Blood. 2006 May 15;107(10):3976-82. Epub 2006 Jan 19.

Supplemental Content

Loading ...
Support Center